
TVRD
Healthcare · Biotechnology · $15.7M market cap
$1.18+0.03 (+2.2%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +20.4% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Before the open | -0.40 | -0.48 | -20.0% |
| Aug 14, 2026 | Before the open | -0.65 | -0.69 | -6.2% |
| May 8, 2026 | Time not confirmed | -0.65 | -0.73 | -12.3% |
| Mar 31, 2026 | After the close | -0.57 | -0.78 | -36.8% |
| Nov 13, 2025 | After the close | -0.81 | -0.59 | +27.2% |
| Aug 14, 2025 | After the close | -0.39 | 0.51 | +230.8% |
| May 13, 2025 | After the close | -0.58 | -0.50 | +13.8% |
| Feb 26, 2025 | Time not confirmed | -0.20 | -5.21 | -2548.7% |
| Nov 29, 2024 | Time not confirmed | -0.24 | -8.19 | -3312.3% |
| Aug 5, 2024 | Time not confirmed | -0.26 | -0.27 | -3.8% |
| May 13, 2024 | Time not confirmed | -0.40 | -0.56 | -40.0% |
| Mar 4, 2024 | Time not confirmed | -0.45 | -0.59 | -31.1% |
| Nov 13, 2023 | Time not confirmed |
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage…
| -0.52 |
| -0.52 |
| 0.0% |
| Aug 7, 2023 | Time not confirmed | -0.54 | -0.58 | -7.4% |
| May 15, 2023 | Time not confirmed | -0.51 | -0.49 | +3.9% |
| Mar 6, 2023 | Time not confirmed | -0.32 | -0.56 | -75.0% |
| Nov 7, 2022 | Time not confirmed | -0.43 | -0.43 | 0.0% |
| Aug 8, 2022 | Time not confirmed | -0.08 | -0.08 | 0.0% |
| May 9, 2022 | Time not confirmed | -0.52 | -0.52 | 0.0% |
| Mar 1, 2022 | Time not confirmed | -0.63 | -0.63 | 0.0% |
| Nov 8, 2021 | Time not confirmed | -0.02 | -0.02 | 0.0% |
| Aug 9, 2021 | Time not confirmed | -0.61 | -0.61 | 0.0% |
| May 10, 2021 | Time not confirmed | -0.47 | -0.47 | 0.0% |
| Feb 25, 2021 | Time not confirmed | 1.59 | 1.59 | 0.0% |
| Nov 9, 2020 | Time not confirmed | -0.35 | -0.35 | 0.0% |
| Aug 10, 2020 | Time not confirmed | -0.54 | -0.54 | 0.0% |
| May 11, 2020 | Time not confirmed | -0.62 | -0.62 | 0.0% |
| Feb 27, 2020 | Time not confirmed | -0.61 | -0.61 | 0.0% |
| Nov 5, 2019 | Time not confirmed | -0.74 | -0.74 | 0.0% |
| Aug 7, 2019 | Time not confirmed | -0.58 | -0.58 | 0.0% |
| May 7, 2019 | Time not confirmed | -0.58 | -0.56 | +3.4% |
| Mar 12, 2019 | Time not confirmed | -0.58 | -0.52 | +10.3% |
| Nov 6, 2018 | Time not confirmed | -0.49 | -0.51 | -4.1% |
| Aug 7, 2018 | Time not confirmed | -0.51 | -0.52 | -2.0% |
| May 10, 2018 | Time not confirmed | — | -18.47 | — |
| Mar 16, 2018 | Time not confirmed | — | -15.64 | — |